HOWL – werewolf therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Werewolf Therapeutics GAAP EPS of -$0.38 beats by $0.07 Nov. 08, 2024 2:25 AM ET By: Manshi Mamtora , CFA [Seeking Alpha]
Werewolf Therapeutics Presents Preclinical and Clinical Data at the Society for Immunotherapy of Cancer’s (SITC) 39th Annual Meeting
Werewolf Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
Werewolf Therapeutics Announces Promising New Development Candidate, WTX-921, a first-of-its-kind IL-10 INDUKINE™ Molecule for Inflammatory Diseases
Werewolf Therapeutics to Present Posters at the Society for Immunotherapy of Cancer’s (SITC) 39th Annual Meeting
Form SC 13G/A Werewolf Therapeutics, Filed by: PFM Health Sciences, LP
Form SC 13G/A Werewolf Therapeutics, Filed by: BANK OF AMERICA CORP /DE/
Form SC 13G/A Werewolf Therapeutics, Filed by: Rubric Capital Management LP
Form SC 13G/A Werewolf Therapeutics, Filed by: Adage Capital Management, L.P.
Form 8-K Werewolf Therapeutics, For: Nov 12
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.